PRCT (PROCEPT BioRobotics) Short-term investments


PRCT PROCEPT BioRobotics Corp PRCT
70 GF Score
Price $20.90
GF Value $93.20
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is PROCEPT BioRobotics Short-term investments?

Short-term investments only applies to insurance companies.

PRCT
70GF Score
PROCEPT BioRobotics Corp PRCT
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PROCEPT BioRobotics (PRCT) Overvalued in 2026?

Based on GuruFocus' analysis, PROCEPT BioRobotics stock appears to be undervalued. The current stock price of $20.90 is trading 77.6% below its estimated GF Value™ of $93.20. GuruFocus considers PROCEPT BioRobotics to be Significantly Undervalued.

Key valuation signals for PRCT:

  • Short-term investments:
  • GF Value™: $93.20 vs. price of $20.90 (77.6% below fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the PRCT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PROCEPT BioRobotics Business Description

Other Exchanges PRCT:Mexico
Address 150 Baytech Drive, San Jose, CA, USA, 95134
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
70GF Score

Get the complete analysis for PRCT

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.90
Price
$93.20
GF Value